There is already a considerable amount of data proving that low peripheral blood NK cell counts [39] as well as reduced levels of CD56+ [40,41], and CD57+ [42,43,44,45] tumor-infiltrating lymphocytes are associated with a poorer prognosis in CRC [46], which correlates with our results in SARIFA-positive cases. Here, B3GAT1 is linked to neoplasm.